SWOG clinical trial number
S0307A

Long-Term Bone Quality in Women With Breast Cancer (A Companion Study to S0307)

Closed
Phase
Accrual
0%
Abbreviated Title
ANCILLARY: S0307 Companion Study
Activated
10/01/2008
Closed
02/01/2010
Participants
Limited: Institutions Listed on the Title Page

Research committees

Breast Cancer

Eligibility Criteria Expand/Collapse

--Must provide consent to be enrolled in S0307;
--Must not have rickets, osteogenesis imperfecta, or osteosclerosis or osteomalacia;
--Must not have used prednisone prior to the diagnosis of breast cancer and within the last 10 years at a dose above 5 mg/day for 3 months or longer;
--Must not be using anticonvulsant medication;
--Must not have hyperparathyroidism;
--Patients must not have had a bone fracture since they were 21 years old unless it was caused by trauma;
--Must not have anorexia nervosa, currently or in the past, as diagnosed by a physician and serious enough to have caused abnormal menstruation;
--Must weigh less than 300 oounds;
--Must not have received any prior bisphosphonate therapy;
--Must not have a history of hypersensitivity to tetracycline or democlocycline.